KLK3 and prostate carcinoma: Many prostate cancers are detected on the basis of elevated plasmatic levels of the prostate-specific antigen (PSA), a glycoprotein normally expressed by prostate tissue, whose levels are often increased in intraprostatic inflammation [71].